Caxton Associates (New York)’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,990	Closed	-$232K	–	461
2023 Q3	$232K	Buy	+3,990	New	+$232K	0.03%	339
2022 Q1	–	Sell	-5,471	Closed	-$252K	–	478
2021 Q4	$252K	Buy	+5,471	New	+$252K	0.03%	431